ARCHIVES

FDA’s Oncologic Drugs Advisory Committee recommended approval of three drugs for cancer, voted down one.

This article is from The Cancer Letter archive.

Vol. 31 No. 33 | September 16, 2005

Download PDF Visit The Full Archive

Related Articles

Reorganization Answer Now Coming In – Viroloy Extramural Research To Be Under Carcinogenesis

March 24, 1978

Tough Year Seen for Cooperative Groups; Priority Payment Questioned

December 2, 1988

NCAB Criticizes Coverage’ Of NCI Screening Statement

March 4, 1994

Oncology Unit – How To Plan, Start It

February 10, 1978

Varmus Discusses Grant Policy, Changes in Congress and Ebola

December 12, 2014

Aranesp Approval Introduces Competition To $1.8 Billion U.S. Cancer Anemia Market

August 2, 2002